Clinical Trial Update: Bortezomib in Treating Patients With Recurrent Glioma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating bortezomib in adults with recurrent glioma; the study has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Anaplastic Oligodendroglioma
• Glioblastoma
• Glioma
• Gliosarcoma

Drugs mentioned

• Bortezomib (bortezomib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma | Phase 1 | Status: TERMINATED